On the basis of inheriting the overall framework and characteristics of the original version, this revision proposes the following revision principles: the existing 9 sub-specialty drug varieties are adjusted and content is added and deleted based on the current clinical drug use; the length of clinical drug guidance and suggestions is further increased and the concept is updated based on the latest guidelines or expert consensus; related drug items are added to record drugs with the closest pharmacological effects, easily confused, and structurally derived drugs.
